SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001659617-20-000196
Filing Date
2020-08-12
Accepted
2020-08-12 07:29:59
Documents
60
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mbx-20200630.htm   iXBRL 10-Q 1476332
2 EX-10.1 exhibit101-mdaamendno3.htm EX-10.1 28186
3 EX-31.1 a2020q2ex311-xnextgen.htm EX-31.1 12550
4 EX-31.2 a2020q2ex312-xnextgen.htm EX-31.2 12257
5 EX-32.1 a2020q2ex321-xnextgen.htm EX-32.1 7225
6 EX-32.2 a2020q2ex322-xnextgen.htm EX-32.2 7327
12 mbx-20200630_g1.jpg GRAPHIC 132868
  Complete submission text file 0001659617-20-000196.txt   6938523

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mbx-20200630.xsd EX-101.SCH 45180
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mbx-20200630_cal.xml EX-101.CAL 58932
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mbx-20200630_def.xml EX-101.DEF 196227
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mbx-20200630_lab.xml EX-101.LAB 538680
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mbx-20200630_pre.xml EX-101.PRE 341214
13 EXTRACTED XBRL INSTANCE DOCUMENT mbx-20200630_htm.xml XML 1248718
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 201094079
SIC: 2834 Pharmaceutical Preparations